Literature DB >> 25635494

Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer.

Li Zhang1, Gustavo Pacheco-Rodriguez, Wendy K Steagall, Jiro Kato, Mary Haughey, Joseph R Fontana, Vincent C Manganiello, Joel Moss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25635494      PMCID： PMC4351575          DOI： 10.1164/rccm.201408-1480LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  24 in total

Review 1.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

2.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Microsatellite DNA instability in COPD.

Authors:  N M Siafakas; E G Tzortzaki; G Sourvinos; D Bouros; N Tzanakis; A Kafatos; D Spandidos
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

4.  Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Authors:  Francis X McCormack; Yoshikazu Inoue; Joel Moss; Lianne G Singer; Charlie Strange; Koh Nakata; Alan F Barker; Jeffrey T Chapman; Mark L Brantly; James M Stocks; Kevin K Brown; Joseph P Lynch; Hilary J Goldberg; Lisa R Young; Brent W Kinder; Gregory P Downey; Eugene J Sullivan; Thomas V Colby; Roy T McKay; Marsha M Cohen; Leslie Korbee; Angelo M Taveira-DaSilva; Hye-Seung Lee; Jeffrey P Krischer; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

5.  Microsatellite DNA instability and loss of heterozygosity in pulmonary sarcoidosis.

Authors:  D A Vassilakis; G Sourvinos; M Markatos; K Psathakis; D A Spandidos; N M Siafakas; D Bouros
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

Authors:  Denise M Crooks; Gustavo Pacheco-Rodriguez; Rosamma M DeCastro; J Philip McCoy; Ji-an Wang; Fumiyuki Kumaki; Thomas Darling; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

7.  Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.

Authors:  Xiong Cai; Gustavo Pacheco-Rodriguez; Qing-Yuan Fan; Mary Haughey; Leigh Samsel; Souheil El-Chemaly; Hai-Ping Wu; J Philip McCoy; Wendy K Steagall; Jing-Ping Lin; Thomas N Darling; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2010-07-16       Impact factor: 21.405

Review 8.  Lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Wendy K Steagall; Joel Moss
Journal:  Cancer Control       Date:  2006-10       Impact factor: 3.302

Review 9.  Lymphangioleiomyomatosis - a wolf in sheep's clothing.

Authors:  Elizabeth P Henske; Francis X McCormack
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

10.  Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Authors:  Sanjukta Chakraborty; S M Azeem Mohiyuddin; K S Gopinath; Arun Kumar
Journal:  BMC Cancer       Date:  2008-06-06       Impact factor: 4.430
View more
  1 in total

Review 1.  The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.

Authors:  Wendy K Steagall; Gustavo Pacheco-Rodriguez; Thomas N Darling; Olga Torre; Sergio Harari; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.